已收盘 03-07 16:00:00 美东时间
0.000
0.00%
“医谷” 近日,强生宣布已成功完成对抗体药物开发公司Ambrx Biopharma的收购。此次收购以全现金合并交易的形式完成,总股权价值约为20亿美元(约14...
2024-03-12 19:10
As previously announced, under the terms of the transaction, Ambrx shareholders will receive $28.00 per share in cash in connection with the closing of the transaction.
2024-03-07 02:21
NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
2024-02-13 02:43